Back

Diazepam modulates hippocampal CA1 functional connectivity in people at clinical high-risk for psychosis

Livingston, N. R.; Kiemes, A.; O'Daly, O.; Knight, S. R.; Lukow, P.; Jelen, L. A.; Reilly, T. J.; Dima, A.; Nettis, M. A.; Casetta, C.; Devenyi, G. A.; Spencer, T.; De Micheli, A.; Fusar Poli, P.; Grace, A. A.; Williams, S. C. R.; McGuire, P.; Chakravarty, M. M.; Egerton, A.; Modinos, G.

2024-12-21 psychiatry and clinical psychology
10.1101/2024.12.20.24319330 medRxiv
Show abstract

BackgroundPreclinical evidence suggests that diazepam enhances hippocampal {gamma}-aminobutyric acid (GABA) signalling and normalises a psychosis-relevant cortico-limbic-striatal circuit. Hippocampal network dysconnectivity, particularly from the CA1 subfield, is evident in people at clinical high-risk for psychosis (CHR-P), representing a potential treatment target. This study aimed to forward-translate this preclinical evidence. MethodsIn this randomised, double-blind, placebo-controlled study, 18 CHR-P individuals underwent resting-state functional magnetic resonance imaging twice, once following a 5mg dose of diazepam and once following a placebo. They were compared to 20 healthy controls (HC) who did not receive diazepam/placebo. Functional connectivity (FC) between the hippocampal CA1 subfield and the nucleus accumbens (NAc), amygdala, and ventromedial prefrontal cortex (vmPFC) was calculated. Mixed-effects models investigated the effect of group (CHR-P placebo/diazepam vs. HC) and condition (CHR-P diazepam vs. placebo) on CA1-to-region FC. ResultsIn the placebo condition, CHR-P individuals showed significantly lower CA1-vmPFC (Z=3.17, PFWE=0.002) and CA1-NAc (Z=2.94, PFWE=0.005) FC compared to HC. In the diazepam compared to placebo condition, CA1-vmPFC FC was significantly increased (Z=4.13, PFWE=0.008) in CHR-P individuals, and both CA1-vmPFC and CA1-NAc FC were normalised to HC levels. In contrast, compared to HC, CA1-amygdala FC was significantly lower contralaterally and higher ipsilaterally in CHR-P individuals in both the placebo and diazepam conditions (lower: placebo Z=3.46, PFWE=0.002, diazepam Z=3.33, PFWE=0.003; higher: placebo Z=4.48, PFWE<0.001, diazepam Z=4.22, PFWE<0.001). ConclusionsThis study demonstrates that diazepam can partially restore hippocampal CA1 dysconnectivity in CHR-P individuals, suggesting that modulation of GABAergic function might be useful in the treatment of this clinical group.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.